Sangamo Therapeutics

+$0.39 (+9.11%) Today
$0.00 (0.00%) As of 10:02 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.

About SGMO

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which comprises inflammatory and autoimmune diseases.

CEO
Alexander D. Macrae
Employees
431
Headquarters
Brisbane, California
Founded
1995

SGMO Key Statistics

Market cap
685.03M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.16M
High today
$4.67
Low today
$4.15
Open price
$4.21
Volume
2.14M
52 Week high
$12.14
52 Week low
$3.12

SGMO Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure